Cardiovascular Innovations and Applications

23/01/2026

This case report describes a novel 'second valve drag and reposition' technique to successfully rescue a self-expanding aortic valve that migrated into the left ventricle during for pure .

:

Presenting "Second valve drag & reposition"- a novel technique to rescue a self-expanding aortic valve that migrated into the left ventricle

23/01/2026

This study identifies circulating TGM2 as a novel prognostic for , demonstrating that elevated TGM2 levels correlate with disease severity and provide significant predictive value for major adverse cardiac events ( ) in ACS patients. Capital Medical University 首都医科大学

:

This study investigates the association between circulating TGM2 levels and the severity of coronary stenosis in acute coronary syndrome (ACS)

23/01/2026

This study found that levels were dose-dependently associated with increased burden in 952 Chinese patients, indicating that uric acid may serve as an accessible and potential therapeutic target for AF burden assessment.

:

Serum uric acid levels correlate with atrial fibrillation burden in a dose-dependent manner, suggesting UA as a potential biomarker and therapeutic target.

22/01/2026

This Cardiovascular Innovations and Applications - CVIA Journal review shows how disrupted —covering , dynamics, , , and stress responses—fuels oxidative injury, , and lipid buildup in , while MQC‑targeted therapies hold promise.

:

Explore how mitochondrial quality control impacts atherosclerosis development and discover emerging therapies targeting MQC pathways to restore vascular health

20/01/2026

Call for Editorial Board Members!

CVIA invites cardiovascular researchers to help lead its scientific mission. 2-year term starting Apr 2026.

Deadline: Mar 31, 2026.

Apply: https://cvia-journal.org/call-for-editorial-board-members-cardiovascular-innovations-and-applications/

16/01/2026

Integrated analysis, , and experimental validation revealed that BTC & KLF15 inhibit (AAA) by maintaining the contractile phenotype and preventing apoptosis, respectively, underscoring their potential as novel and .

:

Identifies BTC & KLF15 in vascular smooth muscle cells as AAA biomarkers via machine learning and in vitro validation, advancing diagnosis/therapy

09/01/2026

This review explores different circulating molecules related to and ECM degradation, regulatory , metabolites, and cellular and vesicular entities as for (AAA), highlighting their prognostic and diagnostic potential.

:

Exploring the circulating biomarkers for abdominal aortic aneurysm (AAA), emphasizing its potential prognostic and diagnostic abilities.

09/01/2026

This review shows that improves outcomes by modulating remodeling, , , and activation, with the trial confirming reduced mortality and hospitalization, highlighting its translational potential.

:

Qiliqiangxin shows promise in heart failure by targeting cardiac remodeling and improving outcomes; clinical trials support its use with standard therapy.

02/01/2026

This retrospective analysis of hospital discharge records identifies , , , etc., as central hub comorbidities among PAH patients, highlighting their critical role in the comorbidity network.

:

Study reveals pulmonary arterial hypertension multimorbidity patterns in Chinese patients via network analysis. Key disorders: cardiovascular, diabetes, lupus.

26/12/2025

This research letter identifies elevated as an independent predictor of reduced emptying velocity in , with a nomogram integrating FGF‑23, AF chronicity, and CHF outperforming CHA2DS2‑VA, offering a tool for risk stratification.

:

Fibroblast growth factor-23 (FGF-23) emerges as a critical predictor of reduced left atrial appendage emptying velocity in AF patients, linking elevated levels to stroke risk via atrial fibrosis.

18/12/2025

This review summarizes -based, imaging-guided, and approaches for predicting and localizing idiopathic ventricular arrhythmias, compares their strengths and limitations, and highlights future directions to improve guidance for .

:

Reviewing ECG, imaging, & AI for premature ventricular contractions (PVCs) localization in outflow tracts. Covers clinical challenges, trends, & IVA innovations.

12/12/2025

This mini review in Cardiovascular Innovations and Applications - CVIA Journal highlights how is advancing diagnosis by improving early detection and prognostic accuracy, while emphasizing risks from data limitations, the promise of , and key ethical and technical challenges ahead.

:

This mini review explores AI's role in Coronary heart disease diagnosis, enhancing accuracy and personalization while addressing challenges in data reliability, ethics, and regulation.